The use of biomaterials implants has become an integral part of modern healthcare in the Western world. Modern healthcare could not even exist without biomaterials. Organ replacement in kidney failure or the restoration of function after oncological surgery (e.g., voice prostheses and limb-saving surgery), trauma (fractures), or due to advanced age (osteoarthritis) would be impossible. The costs of these, however, are enormous. Healthcare spending and follow-up costs exceed U.S. $300 billion dollars in the United States per year and represent between 7 and 8% of total worldwide healthcare spending,1 while the spending pro capita in the United States is U.S. $3724, in Japan U.S. $1759, and in France U.S. $2,215.2 Many healthcare systems in the Western world struggle with these costs, especially in light of the danger of biomaterial-centered infections3 and with the average life expectancy approaching 80 years.
|Number of pages||2|
|Journal||Journal of Biomedical Materials Research. Part B: Applied Biomaterials|
|Publication status||Published - 2004|